Global Pharma Management

Thursday
Mar 18th
  • Login
  • Sign up
    Registration
    Fields marked with an asterisk (*) are required.
    Name: *
    Username: *
    E-mail: *
    Password: *
    Verify Password: *
  • Search
Text size
  • Increase font size
  • Default font size
  • Decrease font size
Home arrow Knowledge Bank arrow Techno Trends arrow Paladin Labs Announces GELICIOUS!(TM) and GELMEG3(TM) Launch
Paladin Labs Announces GELICIOUS!(TM) and GELMEG3(TM) Launch PDF Print E-mail
Thursday, 11 June 2009

Paladin Labs Inc., a leading Canadian specialty pharmaceutical company, today announced the launch of GELICIOUS!TM and GELMEG3TM, the first and only Omega 3 supplements in a tasty gel format, specifically designed for those among us who do not like to and/or cannot swallow pills. Both GELICIOUS!TM for kids and GELMEG3TM for adults contain Health Canada approved key levels of DHA (docosahexanoic acid) and EPA (eicosapentaenoic acid) that previously could have proved difficult for non-fish eaters to ensure they consume as part of their normal daily nutritional intake.

With these branded products Paladin is excited to extend its innovative approach from prescription and OTC products into the realm of nutritional supplements via the BioEnvelop® division. Both Gelicious!TM and GelMeg3TM are not only unique given their creamy orange texture, but both brands are truly satisfying a unique need in the marketplace as research indicates that at least 40% of adults have issues with swallowing pills. For the first time in Canada - a convenient Omega 3 daily supplement that tastes great at room temperature or cold.

About Omega 3

The Omega 3 fatty acid is a form of highly polyunsaturated fat, one of the 'good' fats not naturally manufactured by the human body, is clinically proven to contribute to good health overall, with specific links to brain function, cognitive skills and heart health. Defined as 'essential' to good human health, the two key long chain forms of Omega 3, DHA and EPA, are primarily derived from cold water fish and frequently recommended as supplements to diets low in fish consumption.

About GELICIOUS!TM for Kids

Gelicious!TM is specifically formulated to help support the development of the brain, eyes and nerves among school-aged children, 4-17, in addition to helping to support cognitive skills such as communication and reasoning. Each dose delivers a total of 650mg of DHA (229mg) and EPA (429mg) in a fun tube-like gel pack bursting with orange flavour, ready to be sucked on.

For more information, please visit www.geliciousgels.com.

About GELMEG3TM for Adults

GelMeg3TM contains 1000mg of DHA (343mg) and EPA (658mg), recognized by Health Canada as contributing to the maintenance of good cardiovascular health overall and specifically as an aid in lowering serum triglycerides. Although not as well known as cholesterol, the other lipid/fat present in our blood, high triglyceride levels are clinically proven to be associated with an increased risk of cardiovascular disease.

For more information, please visit www.gelmeg3.com.

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies.

For more information, please visit the Company's web site at www.paladinlabs.com.

About BioEnvelop®

Founded in 1998, BioEnvelop® designs and manufactures state-of-the-art Delivery Systems of Active Ingredients in both film and gel formats that have wide applications in the Medical & Dental, Health & Wellness and Oral Care industries. BioEnvelop® has a license to manufacture under the Natural Health Products (NHP) certification program of Canada. BioEnvelop® continues to offer many new opportunities for Nutraceutical companies to change from a current product format into a new delivery system or just begin with an entirely new product application. In either case, BioEnvelop® has the passion, the resources and the complete focus to execute the introduction of a new product delivery concept to the marketplace and is constantly looking for new technologies and partnerships.

For more information, please visit www.bioenvelop.com.

 
< Prev   Next >

Publication

Global Pharma Management is a leading international magazine, published in India. The magazine is published two times in a year with a circulation figure of 75,015 (print + online, publisher's survey).

Advertising Products

B. Braun is one of the world's leading companies in international health-care.
The principal activities within customer projects are product variation and combination, pharmaceutical contract manufacturing and common development.
Advertisement
Hospital Management Asia
Asia Hospital & Healthcare Circulation
Global Pharma Management
Global Pharmaceutical Circulation.
Hospital & Healthcare Management
Global Hospital & Healthcare circulation
To Join With US
Contact Avni Media Pvt.Ltd.,